oxophenarsine has been researched along with Leukemia in 1 studies
*Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, J; Shi, D; Song, ZL; Xu, Q; Yao, X; Zhang, J | 1 |
1 other study(ies) available for oxophenarsine and Leukemia
| Article | Year |
|---|---|
Structural Modification of Aminophenylarsenoxides Generates Candidates for Leukemia Treatment
Topics: Antineoplastic Agents; Apoptosis; Arsenicals; HL-60 Cells; Humans; Leukemia; Molecular Docking Simulation; Molecular Structure; Oxidative Stress; Reactive Oxygen Species; Structure-Activity Relationship; Thioredoxin-Disulfide Reductase | 2021 |